Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersInfectious Disease Physician in Birmingham, AL
NPI: 1558390971Primary Employer
Birmingham VAMC
va.gov
HQ Phone
Get Sonya's Phone Numberphone_androidMobile
Get Sonya's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
AL State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 22 | 26 |
Interleukin-21-producing HIV-1-specific CD8 T cells are preferentially seen in elite controllers.
Early antibody treatment, inflammation, and risk of post-COVID conditions.
Authors: Eshan Patel, Edward Cachay, Bela Patel, Yuriko Fukuta, Adam Levine, Barry Meisenberg, Karen Lane, Evan Bloch, Kelly Gebo, Donald N Forthal, Judith Currier, Janis Blair, Giselle Mosnaim, Seble Kassaye, James Paxton
Journal: mBio
Publication Date: 2023-09-19
Authors: Spyros Kalams, Eric Alves, Simon Mallal, Mark Pilkinton, Paul Goepfert
Journal: Front Immunol
Publication Date: 2021-10-26
Lead Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Collaborators: National Institute of Allergy and Infectious Diseases (NIAID)
Intervention / Treatment: DRUG: Doravirine 100 Mg, DRUG: Integrase strand transfer inhibitors, DRUG: Tenofovir alafenamide/emtricitabine, DRUG: tenofovir disproxil fumarate/emtricitabine
Lead Sponsor: University of Alabama at Birmingham
Intervention / Treatment: DRUG: Placebo oral tablet, DRUG: Tranexamic acid tablets
Lead Sponsor: University of Alabama at Birmingham
Intervention / Treatment: DRUG: Placebo oral tablet, DRUG: Tranexamic acid